greeksoup/ stock research

American Healthcare REIT (AHR) FY2022 results: revenue $1.4 billion, up 25.6% on the year

American Healthcare REIT, Inc. (AHR) reported revenue of $1.4 billion for fiscal 2022, the year ended 31 December 2022, up 25.6% on the year before. Net income was -$81 million, and diluted earnings per share $-1.24. The figures are the company's own, from the 10-K it filed with the SEC on 17 March 2023.

Revenue
$1.4 billion
+25.6% on the year
FY2016FY2022
Operating margin
21.4%
19.0% a year earlier
FY2016FY2022
Net income
-$81 million
FY2016FY2022
Diluted EPS
-$1.24
FY2016FY2022

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2022 · Q2 FY2022 · Q3 FY2022 · Q4 FY2022

Income statement (profit and loss)

$ millionFY2022FY2021FY2020On the yearLast 8 years
Revenue1,4121,1241,069+25.6%
Cost of revenue1,2821,030994+24.4%
Gross profit13193.775.3+39.4%
Gross margin9.3%8.3%7.0%
Operating income302213218+41.5%
Operating margin21.4%19.0%20.4%
Interest expense10680.971.3+30.9%
Pre-tax income-72.8-52.35.8
Income tax0.61.0-3.1-38.7%
Effective tax raten/an/a-53.2%
Net income-81.3-47.82.2
Net margin-5.8%-4.3%0.2%
Diluted EPS-$1.24-$0.96$0.05
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2022FY2021FY2020On the yearLast 8 years
Operating cash flow14817.9219+724.9%
Capital expenditure7.5n/a8.3
Free cash flow140n/a211
Free cash flow margin9.9%n/a19.7%
Cash from investing-119-139-148
Cash from financing-42.994.1-8.8
Depreciation and amortisation16813398.9+26.1%
Share-based compensation3.98.8-1.3-55.6%
Buybacks20.70.423.1+5,318.6%
Dividends paid51.122.827.0+124.3%
Dividend per share$1.60$0.68$0.45+135.3%
Diluted shares, weighted66m50m45m+31.4%
Shares outstanding at period endn/an/a180m

Balance sheet

$ millionFY2022FY2021FY2020On the yearLast 8 years
Shareholders' equity1,4001,581866-11.5%
Non-controlling interest168176168-4.5%
Debt2,5122,3221,654+8.2%
Other liabilities707501546+41.1%
Total liabilities and equity4,7874,5803,235+4.5%
Goodwill23221075.3+10.3%
Intangible assets236249155-5.1%
Securities held for sale or to maturity83.079.375.9+4.6%
Cash and equivalents65.181.6113-20.3%
Inventory19.818.924.7+4.5%
Other assets4,1513,9422,791+5.3%
Total assets4,7874,5803,235+4.5%

10-K for the year ended 31 December 2022, filed 17 March 2023: the filing.